- Home
- UI vs DGX Comparison
UI vs DGX Comparison
Compare UI & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UI
- DGX
- Stock Information
- Founded
- UI 2003
- DGX 1967
- Country
- UI United States
- DGX United States
- Employees
- UI N/A
- DGX N/A
- Industry
- UI Radio And Television Broadcasting And Communications Equipment
- DGX Medical Specialities
- Sector
- UI Technology
- DGX Health Care
- Exchange
- UI Nasdaq
- DGX Nasdaq
- Market Cap
- UI 20.6B
- DGX 17.5B
- IPO Year
- UI 2011
- DGX 1996
- Fundamental
- Price
- UI $320.93
- DGX $172.26
- Analyst Decision
- UI Buy
- DGX Buy
- Analyst Count
- UI 2
- DGX 13
- Target Price
- UI $331.00
- DGX $177.69
- AVG Volume (30 Days)
- UI 118.8K
- DGX 1.2M
- Earning Date
- UI 02-07-2025
- DGX 01-30-2025
- Dividend Yield
- UI 0.75%
- DGX 1.86%
- EPS Growth
- UI 19.63
- DGX 2.67
- EPS
- UI 7.36
- DGX 7.69
- Revenue
- UI $2,150,681,000.00
- DGX $9,872,000,000.00
- Revenue This Year
- UI $20.30
- DGX $10.18
- Revenue Next Year
- UI $9.57
- DGX $3.82
- P/E Ratio
- UI $43.49
- DGX $22.40
- Revenue Growth
- UI 14.59
- DGX 6.70
- 52 Week Low
- UI $104.24
- DGX $123.66
- 52 Week High
- UI $469.98
- DGX $172.91
- Technical
- Relative Strength Index (RSI)
- UI 31.37
- DGX 70.79
- Support Level
- UI $335.50
- DGX $166.15
- Resistance Level
- UI $469.98
- DGX $172.64
- Average True Range (ATR)
- UI 24.93
- DGX 3.27
- MACD
- UI -8.68
- DGX 0.74
- Stochastic Oscillator
- UI 0.05
- DGX 94.96
About UI Ubiquiti Inc.
Ubiquiti Inc is a wireless and wireline network equipment provider for small Internet service providers and small- and midsize-business integrators. Its product is based on two primary categories namely Service Provider Technology and Enterprise Technology. The company generates maximum revenue from Enterprise Technology. Geographically, it derives a majority of revenue from North America and also has a presence in Europe, the Middle East and Africa; Asia Pacific and South America.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.